Cabral LM

No ORCID on file · 5 papers in corpus · active 2015-2022

Study types

  • article 3
  • other 1
  • preprint 1

Condition tags

  • endometriosis 5
article 2022
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph15111414

BACKGROUND: Current drugs for the treatment of endometriosis are not able to completely cure the condition, and significant side effects hinder the continuation of treatment. Therefore, it is necessary to search for new drug candidates. In …

preprint 2022
·doi:10.20944/preprints202210.0219.v1

Background: Current drug for the treatment of endometriosis is not able of completely cure and significant side effects hinder the continuation of treatment. So, the search for new drug candidates is necessary, and the use of plants extract…

other 2018
Pharmaceutical development and technology ·doi:10.1080/10837450.2017.1290107

Copaiba oleoresin (CPO), obtained from Copaifera landgroffii, is described as active to a large number of diseases and more recently in the endometriosis treatment. In this work, poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing…

article 2016
Materials science & engineering. C, Materials for biological applications ·doi:10.1016/j.msec.2016.03.094

In this work, newly developed nanocomposites based upon lamellar silicates are evaluated to determine their potential in controlling endometriosis. The preparation of the new nanocarriers is detailed, properties characterized and in vitro p…

article 2015
The Journal of pharmacy and pharmacology ·doi:10.1111/jphp.12479

OBJECTIVES: The hormonal treatment for endometriosis frequently fails to completely eradicate endometriotic implants. A new therapeutic treatment is needed. This study investigates the in-vitro effect of Copaifera langsdorffii oil-resin on …